Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-, hydrochloride, hydrate (1:1:2) (ACI)
Terazosin HCl Dihydrate is a fully characterized chemical compound used as a reference standard of API Terazosin. The standard offered is compliant with regulatory guidelines. Terazosin HCl Dihydrate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 70024-40-7
Related products
Terazosin EP Impurity L HCl (Prazosin EP Impurity D HCl)
M.F.
M.W. 180.21 36.46
CAT# AR-T04407
CAS# 60548-09-6
N-Nitroso Terazosin EP Impurity C (N-Nitroso Terazosin USP Related Compound A (Free Form), N-Nitroso Doxazosin EP Impurity G, N-Nitroso Prazosin EP Impurity C)
M.F.
M.W. 318.34
CAT# AR-T04406
CAS# NA
